Daphne Simeon1, Orna Guralnik, Margaret Knutelska
1Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA. daphne.simeon@mssm.edu
This study explored norepinephrine in depersonalization disorder (DPD). Findings suggest heightened noradrenergic activity with anxiety, but a decline in norepinephrine as depersonalization severity increases.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: